| Scibase

Nov 02 2017

SciBase letter from the CEO number 4: Updated strategy and securing our long-term capital needs

Nov 07 2017

SciBase receives order of up to 1 million SEK within a new customer segment in Italy

Nov 09 2017

SciBase receives first commercial order in the US from private clinic in New York

Sep 25 2017

SciBase unveils growth strategy including plans for US launch of Nevisense

Oct 16 2017

Nevisense presented as one of the top ten most important news stories within skin cancer for dermatologists at US congress

Oct 20 2017

The following people have been appointed as members of SciBase Holding's election committee for the Annual General Meeting in 2018:

Oct 26 2017

SciBase Holding AB (publ) proposes a preferential rights issue of SEK 85 million, secured to SEK 75 million

Jun 29 2017

SciBase receives US approval for Nevisense

Jul 10 2017

New Study: Nevisense shows potential to help clinics detect melanomas they might otherwise miss

Aug 18 2017

Interim Report

Subscribe to